By Katie Thomas and Noah Weiland from NYT Health
The treatment, made by the biotech company Regeneron, is a cocktail of two powerful antibodies that have shown promise for people who get it early in the course of the disease.
https://ift.tt/3fkqXKY
November 21, 2020 at 06:00AM
0 Comments
Share your opinion